CMI Ltd. - Research Center
517330 CMI Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Sales | 8.04 | 14.85 | 22.26 | 22.60 | 68.06 |
| Operating profit | -72.11 | -1.80 | -0.74 | -10.67 | -9.93 |
| Interest | 10.06 | 11.43 | 11.67 | 10.90 | 13.79 |
| Gross profit | -80.36 | -12.67 | -12.14 | -21.03 | -22.44 |
| EPS (Rs) | -24.35 | -7.02 | -46.59 | -11.20 | -96.98 |
Quarterly
results in details
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Other income | 1.81 | 0.55 | 0.27 | 0.54 | 1.29 |
| Stock adjustment | 6.68 | -0.58 | 2.15 | -12.90 | 21.55 |
| Raw material | 6.08 | 14.43 | 16.76 | 42.43 | 51.87 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.25 | 1.09 | 1.68 | 1.69 | 1.76 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 66.14 | 1.69 | 2.41 | 2.05 | 2.80 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.61 | 2.58 | 2.60 | 2.65 | 2.96 |
| Taxation | -15.80 | -4.02 | -12.68 | -6.03 | -10.41 |
| Net profit / loss | -39.03 | -11.25 | -74.67 | -17.95 | -155.44 |
| Extra ordinary item | 28.14 | -0.02 | -72.61 | -0.29 | -140.45 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 16.03 | 16.03 | 16.03 | 16.03 | 16.03 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -896.41 | -12.10 | -3.33 | -47.24 | -14.59 |
| GPM (%) | -815.37 | -82.26 | -53.86 | -90.90 | -32.36 |
| NPM (%) | -396.05 | -73.06 | -331.39 | -77.56 | -224.15 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis